$IOVA

Iovance Biotherapeutics Inc

  • NASDAQ/NMS (GLOBAL MARKET)
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Biological Product (except Diagnostic) Manufacturing

PRICE

$22.27 -

Extented Hours

VOLUME

1,244,813

DAY RANGE

22.01 - 22.9

52 WEEK

15.88 - 54.21

Join Discuss about IOVA with like-minded investors

profile
@DarkPoolAlgo #Dark Pool Charts
recently

SCAN RESULTS - BULLISH BOTTOMS $DISCA, $CHGG, $STNE, $ATVI, $PSX, $AZEK, $ETSY, $FTCH, $POSH, $UAA, $SNAP, $PFGC, $BMRN, $CAT, $BIGC, $AVLR, $RSX, $BKR, $COUP, $STNE, $LI, $LESL, $BMBL, $PTON, $IOVA, $RUBY TOPS $ATVI, $FTCH, $FVRR, $IFT, $SBH, $SONY, $YUM, $CVS, $NVST, $CAT, $SYK, $TDC, $TWLO, $RSX, $AMZN, $ALXN BEARISH $BK, $ELS, $KMX, $MCK, $NIO, $WFC, $NVDA, $TLT, $VALE, $INFY

75 Replies 9 👍 10 🔥

profile
@ivtrades-Chris #ivtrades
recently

SWEEP DETECTED: >>1657 $IOVA Aug21 25.0 Calls trade $3.869 ASKSIDE [MULTI] 09:52:55 IV=89.2% +13.0 OPENING Vol=1660, OI=106,

133 Replies 8 👍 6 🔥

profile
@dros #droscrew
recently

4500 $IOVA AUG2021 $35 Cs trade 0.85

67 Replies 14 👍 7 🔥

profile
@dros #droscrew
recently

4500 $IOVA AUG2021 $35 Cs trade 0.85

77 Replies 6 👍 9 🔥

profile
@DarkPoolAlgo #Dark Pool Charts
recently

/*============================================= = Monday June 07, 2021 = =============================================*/ Monday, June 7, 2021 Futures Up/Down % Last Dow 30.00 0.09% 34,772 S&P 500 -4.25 0.10% 4,224 Nasdaq -45.50 0.33% 13,721 U.S. futures are mixed to start the trading week as the Dow rises, S&P little changed and Nasdaq futures slide about 45 points as shares of U.S. tech giants decline after the Group of Seven (G7) advanced economies agreed this weekend to back a minimum global tax rate of at least 15% (watch shares of $AAPL, $AMZN, $FB, $GOOGL). Apple (AAPL) will kick off its annual Worldwide Developer Conference at 1 p.m. ET. In healthcare, all eyes on Biogen ($BIIB) as the company rises ahead of FDA decision on Alzheimer’s drug aducanumab as the FDA is set to decide on whether to approve company’s controversial Alzheimer’s disease drug. This weekend, Treasury Secretary Janet Yellen said President Joe Biden should push forward with his $4 trillion spending plans even if they cause an inflation spike into next year. She also told Bloomberg in an interview that slightly higher interest rates would be a plus. Other than that, a quiet day for economic data. Stocks climbed on Friday as the key May jobs report showed solid gains, boosting confidence in the economic comeback, while for the week, the S&P rose 0.62%, the Dow added 0.66%, the Nasdaq gained 0.48%. Bitcoin and most other top cryptocurrencies fell on Sunday on concerns that there may be a further crackdown on the industry in China and as a report from Goldman Sachs Group Inc. served as a reminder that institutional adoption may be a long process. In Asian markets, The Nikkei Index rose 77 points to settle at 29,020, the Shanghai Index rose 7 points to 3,599, and the Hang Seng Index slipped -130 points to 28,787. In Europe, the German DAX is up about 35 points to 15,725, while the FTSE 100 is up around 20 points to 7,090. Market Closing Prices Yesterday The S&P 500 Index jumped 37.04 points, or 0.88%, to 4,229.89 The Dow Jones Industrial Average rose 179.39 points, or 0.52%, to 34,756.39 The Nasdaq Composite surged 199.99 points, or 1.47%, to 13,814.49 The Russell 2000 Index advanced 7.16 points, or 0.31% to 2,286.41 Events Calendar for Today 3:00 PM EST Consumer Credit for April Earnings Calendar: Earnings Before the Open: $GII Earnings After the Close: $BBCP, $COUP, $HQY, $MRVL, $MTN, $NAPA, $REVG, $SFIX Other Key Events: American Society of Clinical Oncology (ASCO), 6/4-6/8 Deutsche Bank Global Consumer Conference (virtual), 6/7-6/10 Goldman Sachs Travel & Leisure Conference 2021 (virtual), 6/7-6/8 Oppenheimer Virtual Software & Semiconductor Bus Tour, 6/7-6/11 Macro Up/Down Last Nymex -0.39 69.23 Brent -0.43 71.46 Gold -5.90 1,885.70 EUR/USD -0.0015 1.2152 JPY/USD -0.04 109.48 10-Year Note +0.019 1.579% World News The G7 reached a landmark deal on Saturday to squeeze more money out of multinational companies such as Amazon and Google and reduce their incentive to shift profits to low-tax offshore havens. Hundreds of billions of dollars could flow into the coffers of governments left cash-strapped by the COVID-19 pandemic after the Group of Seven (G7) advanced economies agreed to back a minimum global corporate tax rate of at least 15%. Treasury Secretary Janet Yellen said President Joe Biden should push forward with his $4 trillion spending plans even if they trigger inflation that persists into next year and higher interest rates. “If we ended up with a slightly higher interest rate environment it would actually be a plus for society’s point of view and the Fed’s point of view,” Yellen said Sunday in an interview with Bloomberg News Sector News Breakdown Consumer Las Vegas is making a comeback according to Barron’s saying bookings at casino resorts have gone up, but convention and expo business still faces uncertainty after the pandemic. Among REITs, MGM Growth Properties ($MGP) and VICI Properties ($VICI) offer yields above 4%. Two major Las Vegas Strip players are MGM Resorts International ($MGM) and Caesars Entertainment ($CZR). Regional casinos Boyd Gaming ($BYD) and Red Rock Resorts ($RRR), which cater more to the local market, have gained more than MGM and Caesars since the end of last January. Avis Budget Group Inc ($CAR) board approved a $325 mln increase to company’s share repurchase authorization Lordstown Motors ($RIDE) said it received a notice of delinquency for late filing from the Nasdaq Stock Market because it has yet to file its 10-Q for the quarter ended March 31 Reckitt Benckiser Group Plc agreed to sell its Chinese baby-formula business to Primavera Capital Group for $2.2 billion as the company seeks to exit from the struggling sector. Reckitt will retain an 8% stake in the unit and sees net cash proceeds of about $1.3 billion Tesla ($TSLA) CEO Elon Musk told Twitter followers that the Plaid+ trim is “canceled” as the imminent, lower-priced ‘regular’ Plaid model is “just so good.” It’s the quickest production car ever, he claimed Energy, Industrials and Materials Peabody Energy ($BTU) files to say has entered into at market issuance sales agreement to offer and sell up to 12.5 mln shares of common stock Diana Shipping Inc. ($DSX) files for mixed shelf of up to $750 mln TimkenSteel ($TMST) announced it will increase base pricing on all special bar quality products by $50 per ton Trucker rating changes at Goldman Sachs as they upgraded CH Robinson ($CHRW) to Buy from Sell with a $108 price target saying asset-based truckload sector fundamentals are very robust right now with supply tight, demand strong and prices elevated, while the firm downgraded ArcBest (ARCB) to Neutral and Werner ($WERN) to Sell Financials Barron’s said Allegiance Bancshares ($ABTX), PNC Financial Services Group ($PNC), Pinnacle Financial Partners ($PNFP), SVB Financial Group ($SIVB) are banks that operate in regions where growth is booming, and they can benefit from loan growth sooner Realty Income Corp ($O) files mixed securities shelf Essex Property ($ESS) raises low end of core FFO guidance for Q2 and FY21 as now sees Q2 core FFO of $2.92-3.00 (prior: $2.84-3.00) vs. a consensus of $2.98; sees FY21 core FFO of $12.02-12.46 (prior: $11.46-$12.46) vs. $12.23 consensus. Visa ($V) upgraded to Overweight from Neutral at Piper Sandler and up tgt to $260 from $234 Healthcare Biogen ($BIIB) rises ahead of FDA decision on Alzheimer’s drug aducanumab as the FDA is set to decide on whether to approve company’s controversial Alzheimer’s disease drug. If approved, Biogen’s aducanumab would be the first treatment in more than a decade to treat the disease (other companies with Alzheimer treatments include $AVXL, $PRTA, $SAVA) ChromaDex Corp. ($CDXC) announced the launch of its flagship consumer product Tru Niagen(R) in Walmart, available in 3,800 stores across the United States. Walmart is the first major U.S. retailer to bring this well-studied healthy aging nutrient to stores Fate Therapeutics ($FATE) upgraded to Buy from Neutral at H.C. Wainwright Liminal BioSciences ($LMNL) shares jumped post-market Friday after the U.S. FDA approved Ryplazim for the treatment of patients with plasminogen deficiency type 1 (hypoplasminogenia) Iovance Biotherapeutics ($IOVA) announced updated clinical data for lifileucel from Cohort 2 in the C-144-01 clinical study in patients with advanced melanoma. The data were presented in an oral presentation at the ASCO 2021 Annual Meeting Novartis ($NVS) announced Phase 2 primary endpoint data showing investigational iptacopan – a first-in-class, oral, targeted factor B inhibitor – reduced protein in the urine, an increasingly recognized surrogate marker correlating with progression to kidney failure, and showed promise in stabilizing kidney function in patients with IgA nephropathy, or IgAN Technology, Media & Telecom Apple ($AAPL) will debut major software updates for the iPhone and iPad at its developers’ conference this week Software maker PTC ($PTC) is up 60% over the past two years, but it has more upside as it seeks to dominate the Internet of Things, Barron’s says. Autodesk ($ADSK) confirmed that it has submitted a non-binding proposal to acquire all the outstanding shares of common stock of Altium ($ALMFF) for A$38.50 Flextronics ($FLEX) forecasted that the chip shortage disrupting the car industry and the supply of consumer technology products will last until at least mid-2022 – Financial Times reported

89 Replies 6 👍 7 🔥

profile
@Trollypolly #StockTraders.NET
recently

IOVA long at 16.34 is playing out nicely 

94 Replies 13 👍 12 🔥

profile
@maletone #StockTraders.NET
recently

$IOVA might have bottomed out

75 Replies 6 👍 12 🔥

profile
@dros #droscrew
recently

3880 $IOVA JUN2021 $40 Cs bought 2.5

142 Replies 14 👍 6 🔥

profile
@dros #droscrew
recently

3880 $IOVA JUN2021 $40 Cs bought 2.5

49 Replies 14 👍 8 🔥

profile
@ivtrades-Chris #ivtrades
recently

3880 $IOVA Jun21 40.0 Calls trade $2.50 (FT Theo=1.56) Above Ask! [CBOE] 12:42:34 IV=115.1% +29.6 FLOOR - OPENING Vol=5408, OI=2883,

104 Replies 14 👍 15 🔥

profile
@Carlos-carvan58 #ivtrades
recently

2,150 $IOVA 100 15 JAN 21 40 PUT @1.65 LMT

62 Replies 15 👍 7 🔥

profile
@Carlos-carvan58 #ivtrades
recently

$IOVA 40P Jan21

95 Replies 13 👍 7 🔥

profile
@Carlos-carvan58 #ivtrades
recently

$IOVA 50C Nov

44 Replies 11 👍 6 🔥

profile
@thegiz18 #ivtrades
recently

$IOVA buy was 2 wks ago on negative drug review news

145 Replies 13 👍 9 🔥

profile
@Carlos-carvan58 #ivtrades
recently

ops sorry $IOVA

68 Replies 11 👍 10 🔥

profile
@Carlos-carvan58 #ivtrades
recently

$iova 45c NEXT WEEK

137 Replies 13 👍 11 🔥

profile
@Carlos-carvan58 #ivtrades
recently

$IOVA to $50

143 Replies 7 👍 6 🔥

Key Metrics

Market Cap

3.40 B

Beta

1.39

Avg. Volume

1.62 M

Shares Outstanding

152.85 M

Yield

0%

Public Float

0

Next Earnings Date

2021-08-05

Next Dividend Date

Company Information

Iovance Biotherapeutics aims to improve patient care by making T cell-based immunotherapies broadly accessible for the treatment of patients with solid tumors and blood cancers. Tumor infiltrating lymphocyte (TIL) therapy uses a patient's own immune cells to attack cancer. TIL cells are extracted from a patient's own tumor tissue, expanded through a proprietary process, and infused back into the patient. Upon infusion, TIL reach tumor tissue, where they attack cancer cells. The company has completed dosing in pivotal programs in patients with metastatic melanoma and cervical cancer. In addition, the company's TIL therapy is being investigated in a registration-supporting study for the treatment of patients with locally advanced, recurrent or metastatic non-small cell lung cancer. Clinical studies are also underway to evaluate TIL in earlier stage cancers in combination with currently approved treatments, and to investigate Iovance peripheral blood lymphocyte (PBL) T cell therapy for blood cancers.

CEO: Maria Fardis

Website:

HQ: 999 Skyway Rd Ste 150 San Carlos, 94070-2724 California

Related News

  • Intrado Digital Media

    Iovance Biotherapeutics to Host Second Quarter Financial Results Conference Call and Webcast on Thursday, August 5, 2021

    19 Jul 2021, 20:30
  • SBWire

    NASDSQ:IOVA Shareholder Alert: Investigation Concerning Possible Wrongdoing at Iovance Biotherapeutics, Inc.

    01 Jul 2021, 16:15
  • Intrado Digital Media

    Iovance Biotherapeutics to Host Conference Call and Webcast to Discuss Clinical Data for LN-145 in Non-Small Cell Lung Cancer on June 29, 2021 at 4:30pm ET

    29 Jun 2021, 19:38
  • Stocks News Feed

    Iovance Biotherapeutics Announces Clinical Data for LN-145 in Non-Small Cell Lung Cancer - Stocks News Feed

    29 Jun 2021, 10:30
  • Insider Monkey

    Is Iovance Biotherapeutics, Inc. (IOVA) A Good Stock To Buy?

    28 Jun 2021, 19:19